The future of advanced manufacturing in the U.S. is being built at innovative facilities that enable experimentation in process and product development. The people and organizations at these next-generation facilities are part of a collaborative effort to remove barriers of entry and create an ecosystem to build supply chains and provide a path...
Our Network @ Work
Learn more about the Manufacturing USA network of institutes and the real-world results their work delivers every day.
There is growing awareness that the long-standing unmet need for specific counting of therapeutic tissue stem cells has been and continues to be a significant impediment to progress in stem cell therapy, gene and gene editing therapies (because targeting tissue stem cells is essential for durable one-time treatments), and drug development (because...
The RACER Blueprint is comprised of Five key factors, in addition to manufacturing, that are essential to a good idea making it from an academic achievement to part of a clinician’s armamenterium. They are as important as the scientific and engineering foundations of a TEMP (or other advanced therapy) with respect to full commercialization.
· R e...
My name is Sarah Boermeester, and I’m currently a summer intern at ARMI. I’m a rising junior at Worcester Polytechnic Institute, where I study Biomedical Engineering with a concentration in Tissue Engineering. When I’m not studying I love being outdoors, painting, and being with family and friends. My educational background revolves around...
ASME recently sponsored a briefing on Capitol Hill in partnership with the House Manufacturing Caucus to highlight the challenges facing regenerative medicine. The briefing, titled “Organs on Demand: What’s Stopping Us from Made-to-Order Tissues and Organs,” brought together leaders in the field of regenerative medicine who are working to take this...